Black Diamond Therapeutics, Inc. (BDTX) — DEF 14A Filings
All DEF 14A filings from Black Diamond Therapeutics, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Black Diamond Therapeutics Files Definitive Proxy Statement
— Apr 18, 2025 Risk: low
Black Diamond Therapeutics, Inc. filed its definitive proxy statement on April 18, 2025, for its annual meeting on June 12, 2025. The company, previously known -
Black Diamond Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 24, 2024 Risk: low
Black Diamond Therapeutics, Inc. (BDTX) filed a Proxy Statement (DEF 14A) with the SEC on April 24, 2024. The 2024 Annual Meeting of Stockholders for Black Diam
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX